Swedish Orphan Biovitrum AB (publ) (STO: SOBI)
320.00
+0.40 (0.13%)
Aug 30, 2024, 5:29 PM CET
SOBI Revenue
Swedish Orphan Biovitrum AB had revenue of 5.44B SEK in the quarter ending June 30, 2024, with 11.70% growth. This brings the company's revenue in the last twelve months to 23.71B, up 17.96% year-over-year. In the year 2023, Swedish Orphan Biovitrum AB had annual revenue of 22.12B with 17.74% growth.
Revenue (ttm)
23.71B
Revenue Growth
+17.96%
P/S Ratio
4.56
Revenue / Employee
13.38M
Employees
1,772
Market Cap
109.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
Dec 31, 2019 | 14.25B | 5.11B | 55.90% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.04B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |
Vimian Group AB (publ) | 3.91B |
Swedish Orphan Biovitrum AB News
- 23 days ago - Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases - Benzinga
- 5 months ago - Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 9 months ago - Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 1 year ago - Bulletin from Swedish Orphan Biovitrum (Sobi)'s Extraordinary General Meeting (EGM) - PRNewsWire
- 1 year ago - Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 1 year ago - New number of shares and votes in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 1 year ago - Swedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosing - PRNewsWire
- 1 year ago - CTI BioPharma Soars After Agreeing $1.7 Billion Sale. Biotech Deals Keep Coming. - Barrons